Abstract:The incidence of human herpesvirus (HHVs) is gradually increasing and has affected a wide range of population. HHVs can result in serious consequences such as tumors, neonatal malformations, sexually transmitted diseases, as well as pose an immense threat to the human health. The cGAS-STING pathway is one of the innate immune pattern-recognition receptors discovered recently. This article discusses the role of the cGAS-STING pathway in human diseases, especially in human herpesvirus infections, as well as highlights how these viruses act on this pathway to evade the host immunity. Moreover, the author provides a comprehensive overview of modulators of the cGAS-STING pathway. By focusing on the small molecule compounds based on the cGAS-STING pathway, novel targets and concepts have been proposed for the development of antiviral drugs and vaccines, while also providing a reference for the investigation of disease models related to the cGAS-STING pathway. HHV is a double-stranded DNA virus that can trigger the activation of intracellular DNA sensor cGAS, after which the host cells initiate a cascade of reactions that culminate in the secretion of type I interferon to restrict the viral replication. Meanwhile, the viral protein can interact with various molecules in the cGAS-STING pathway. Viruses can evade immune surveillance and maintain their replication by inhibiting the enzyme activity of cGAS and reducing the phosphorylation levels of STING, TBK1 and IRF3 and suppressing the interferon gene activation. Activators and inhibitors of the cGAS-STING pathway have yielded numerous promising research findings in vitro and in vivo pertaining to cGAS/STING-related disease models. However, there remains a dearth of small molecule modulators that have been successfully translated into clinical applications, which serves as a hurdle to be overcome in the future.

Import of extracellular 2'-3'cGAMP by the folate transporter, SLC19A1, establishes an antiviral response that limits herpes simplex virus-1

Herpes Simplex Virus-1 targets the 2’-3’cGAMP importer SLC19A1 as an antiviral countermeasure

Transfer of Cgamp into Bystander Cells Via LRRC8 Volume-Regulated Anion Channels Augments STING-Mediated Interferon Responses and Anti-viral Immunity.

Connexin-Dependent Transfer of cGAMP to Phagocytes Modulates Antiviral Responses

Herpes Simplex Virus 1 Tegument Protein VP22 Abrogates Cgas/sting-Mediated Antiviral Innate Immunity

Alternative cGAS signaling promotes Herpes simplex encephalitis

HSV-1 employs UL56 to antagonize expression and function of cGAMP channels

Toxicity of extracellular cGAMP and its analogs to T cells is due to SLC7A1-mediated import

cGAMP the travelling messenger

Cytosolic Sensing of HIV by Cgas (INM2P.350)

Cell-to-cell communications of cGAS-STING pathway in tumor immune microenvironment.

The Solute Carrier Transporter SLC15A3 Participates in Antiviral Innate Immune Responses Against Herpes Simplex Virus-1

Pivotal Roles of Cgas-Cgamp Signaling in Antiviral Defense and Immune Adjuvant Effects

LL-37 Transports Immunoreactive Cgamp to Activate STING Signaling and Enhance Interferon-Mediated Host Antiviral Immunity.

Species-Specific Deamidation of Cgas by Herpes Simplex Virus UL37 Protein Facilitates Viral Replication

The battle between the innate immune cGAS-STING signaling pathway and human herpesvirus infection

Inhibition of cGAS DNA Sensing by a Herpesvirus Virion Protein

Innate Immune Activation by Cgmp-Amp Nanoparticles Leads to Potent and Long-Acting Antiretroviral Response Against HIV-1.

2′3′-cGAMP interactome identifies 2′3′-cGAMP/Rab18/FosB signaling in cell migration control independent of innate immunity

An alternatively spliced STING isoform localizes in the cytoplasmic membrane and directly senses extracellular cGAMP

Extracellular ISG15 triggers ISGylation via a type-I interferon independent non-canonical mechanism to regulate host response during virus infection